CEACAM5 and breast cancer: The aim of this study was to evaluate the efficacy of using 18F-FDG PET/CT along with serum TMs (CEA, CA 125, and CA 15-3) in monitoring the recurrence and metastasis of BC in order to optimize their utility in clinical practice.